Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine/Yale New Haven Hospital
mi
from
New Haven, CT
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine/Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
University of Illinois Hospital and Health Center
mi
from
Chicago, IL
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
University of Illinois Hospital and Health Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Pulmonary and Critical Care Associates of Baltimore
mi
from
Baltimore, MD
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Pulmonary and Critical Care Associates of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian/Columbia University Medical Center
mi
from
New York, NY
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian/Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Temple
mi
from
Philadelphia, PA
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Temple
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Emphysema COPD Research Center, University of Pittsburgh
mi
from
Pittsburgh, PA
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Emphysema COPD Research Center, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Pulmonary, Critical Care & Sleep Medicine Consultants,PCCS/St. Luke's Episcopal Hospital
mi
from
Houston, TX
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Pulmonary, Critical Care & Sleep Medicine Consultants,PCCS/St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Sciences Center at San Antonio
mi
from
San Antonio, TX
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Sciences Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Franciscan Research Center
mi
from
Tacoma, WA
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Franciscan Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated:  12/31/1969
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
mi
from
Quebec,
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
Status: Enrolling
Updated: 12/31/1969
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
mi
from
Quebec,
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Jasper Summit Research, LLC
mi
from
Jasper, AL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Jasper Summit Research, LLC
mi
from
Jasper, AL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Connection
mi
from
Flagstaff, AZ
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Connection
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Pulmonary Associates, PA
mi
from
Phoenix, AZ
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Pulmonary Associates, PA
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Radin Cardiovascular Medical Associates
mi
from
Newport Beach, CA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Radin Cardiovascular Medical Associates
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Western Connecticut Medical Group PC
mi
from
Danbury, CT
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Western Connecticut Medical Group PC
mi
from
Danbury, CT
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Waterbury Pulmonary Associates
mi
from
Waterbury, CT
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Waterbury Pulmonary Associates
mi
from
Waterbury, CT
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Bay Area Chest Physicians
mi
from
Clearwater, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Bay Area Chest Physicians
mi
from
Clearwater, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Gary J. Richmond, M.D., P.A.
mi
from
Fort Lauderdale, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Gary J. Richmond, M.D., P.A.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
East Coast Institute for Research
mi
from
Jacksonville, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
East Coast Institute for Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Pulmonary Disease Specialists
mi
from
Kissimmee, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Pulmonary Disease Specialists
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
San Marcus Research Clinic
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
South Florida Research Phase I-IV, Inc.
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
South Florida Research Phase I-IV, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
IMIC, Inc.
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
IMIC, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Health & Life Research Solutions Inc.
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Health & Life Research Solutions Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Research
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
St. Paul Medical Research Center Inc.
mi
from
Miami, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
St. Paul Medical Research Center Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Advanced Research Institute, Inc
mi
from
New Port Richey, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Advanced Research Institute, Inc
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Concept Clinical Trials, LLC
mi
from
Tamarac, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Concept Clinical Trials, LLC
mi
from
Tamarac, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Axcess Medical Research
mi
from
Wellington, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Axcess Medical Research
mi
from
Wellington, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Florida Premier Research Institute
mi
from
Winter Park, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Florida Premier Research Institute
mi
from
Winter Park, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
River Birch Research Alliance
mi
from
Blue Ridge, GA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
River Birch Research Alliance
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Medical Associates of North Georgia
mi
from
Canton, GA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Medical Associates of North Georgia
mi
from
Canton, GA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Veritas Clinical Specialties, LTD
mi
from
Topeka, KA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Veritas Clinical Specialties, LTD
mi
from
Topeka, KA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Graves-Gilbert Clinic
mi
from
Bowling Green, KY
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Graves-Gilbert Clinic
mi
from
Bowling Green, KY
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Kentucky Research Group
mi
from
Louisville, KY
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
MedPharmics, LLC.
mi
from
Metairie, LA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
MedPharmics, LLC.
mi
from
Metairie, LA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center-Weiler Division
mi
from
Bronx, NY
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center-Weiler Division
mi
from
Bronx, NY
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
American Health Research Inc.
mi
from
Charlotte, NC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
American Health Research Inc.
mi
from
Charlotte, NC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Temple Lung Center Pulmonary & Critical Care Medicine
mi
from
Philadelphia, PA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Temple Lung Center Pulmonary & Critical Care Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials